{"pageContent": "Objective: To characterize the clinicopathological findings and the outcome of human immunodeficiency virus (HIV)-infected patients diagnosed and treated for prostate carcinoma, as HIV-positive men being treated with highly active antiretroviral therapy (HAART) are living longer and thus are more likely to develop cancers such as prostate cancer.", "metaData": {"source": "The lived experience of men diagnosed with prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/22940524/"}}